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Frequency of critical stenosis in primary
arteriovenous fistulae before hemodialysis access:
Should duplex ultrasound surveillance be the
standard of care?
Jennifer Grogan, MD, Maria Castilla, BS, RVT, Laurie Lozanski, BS, RVT, Andrea Griffin, RDMS,
Frank Loth, PhD, and Hisham Bassiouny, MD, Chicago, Ill
Objective: Increasing use of primary arteriovenous fistulae (pAVFs) is a desired goal in hemodialysis patients (National
Kidney Foundation /Dialysis Outcome Quality Initiative guidelines). However, in many instances, pAVFs fail to
adequately mature due to ill-defined mechanisms. We therefore investigated pAVFs with color duplex ultrasound (CDU)
surveillance 4 to 12 weeks postoperatively to identify hemodynamically significant abnormalities that may contribute to
pAVF failure.
Methods: FromMarch 2001 toOctober 2003, 54 upper extremity pAVFs were subjected to CDU assessment before access.
A peak systolic velocity ratio (SVR) of >2:1 was used to detect >50% stenosis involving arterial inflow and venous
outflow, whereas an SVR of >3:1 was used to detect >50% anastomotic stenosis. CDU findings were compared with
preoperative vein mapping and postoperative fistulography when available.
Results: Of 54 pAVFs, there were 23 brachiocephalic, 14 radiocephalic, and 17 basilic vein transpositions. By CDU
surveillance, 11 (20%) were occluded and 14 (26%) were negative. Twenty-nine (54%) pAVFs had 38 hemodynamically
significant CDU abnormalities. These included 16 (42%) venous outflow, 13 (34%) anastomotic, and 2 (5%) inflow
stenoses. In seven (18%), branch steal with reduced flow was found. In 35 of 54 (65%) pAVFs, preoperative vein mapping
was available and demonstrated adequate vein size (>3 mm) and outflow in 86% of cases. Twenty-one fistulograms (38%)
were available for verifying the CDU abnormalities. In each fistulogram, the arterial inflow, anastomosis, and venous
outflow were compared with the CDU findings (63 segments). The sensitivity, specificity, and accuracy of CDU in
detecting pAVF stenoses >50% were 93%, 94%, was 97%, respectively.
Conclusions: Before initiation of hemodialysis, an unexpectedly high prevalence of critical stenoses was found in patent
pAVFs using CDU surveillance. These de novo stenoses appear to develop rapidly after arterialization of the upper
extremity superficial veins and can be reliably detected by CDU surveillance. Turbulent flow conditions in pAVFs may
play a role in inducing progressive vein wall and valve leaflet intimal thickening, although stenoses may be due to venous
abnormalities that predate AVF placement. Routine CDU surveillance of pAVFs should be considered to identify and
correct flow-limiting stenoses that may compromise pAVF long-term patency and use. (J Vasc Surg 2005;41:1000-6.)More than 290,000 individuals are hemodialysis de-
pendent in the United States, and it is estimated that this
population will double by 2010.1 Hemodialysis access fail-
ure is a major cause of morbidity and multiple hospital
admissions. Furthermore, the estimated cost for vascular
access morbidity exceeds 2 billion dollars annually.1,2 Arte-
riovenous fistulae (pAVFs) are recognized as the gold stan-
dard of hemodialysis access because of superior long-term
patency and lower infection and intervention rates when
compared with prosthetic conduits.3-5
The Vascular Access Work Group, of the National
Kidney Foundation (NKF), identified two primary goals to
improve quality of life and overall outcomes for patients on
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1000hemodialysis. The first is to increase the prevalence and use
of native AVFs. The second is to detect access dysfunction
before occlusion. These goals are addressed in the Dialysis
Outcome Quality Initiative (DOQI) guidelines.3 The ulti-
mate goal is that pAVFs be constructed in at least 50% of all
new patients with end-stage renal disease and that 40% of
patients undergo hemodialysis via a pAVF. Currently in the
United States, only 31% of patients on hemodialysis dialyze
through an AVF, and the incidence of AVF creation is a
disappointing 28%. This failure is particularly concerning
when one considers that 80% of prevalent patients on
hemodialysis in Europe dialyze through pAVFs.6 Ascher et
al4 have reported an increase in pAVF placement to at least
80% in their study cohort when DOQI guidelines are
strictly followed, with a 1-year primary patency rate of 85%.
The etiology of such poor pAVF prevalence rates in the
United States is multifactorial and includes inadequate
patient selection, surgical preference, and suboptimal tech-
nique during traumatic cannulation.
In April 2004, the need to improve AVF use was
further emphasized when the Centers for Medicare and
Medicaid announced a national initiative (National Vascu-
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tice patterns that would increase pAVF use in patients on
Medicare. The NVAII statement recommends a multidis-
ciplinary implementation of protocol-driven surveillance
programs for early detection and treatment of failing vas-
cular access conduits.7 The value of a multidisciplinary
approach to hemodialysis access was emphasized in a pro-
spective study by Allon et al,8 which demonstrated a de-
crease in access failure and an increase in AVF creation in
new patients on dialysis from 33% to 69%.
To date, the results of color duplex ultrasound (CDU)
pAVF surveillance in the first 2 to 3 months postoperatively
are not known. The purpose of this retrospective study was
to determine the prevalence of hemodynamically significant
abnormalities in pAVFs before access cannulation using a
standard protocol of CDU surveillance. We further vali-




In this retrospective study (March 2001 to October
2003), we reviewed the CDU surveillance findings of pa-
tients referred for evaluation of upper extremity pAVFs in
54 patients within 3 months of fistula creation and before
initiation of hemodialysis. During this study period, a total
of 263 patients underwent AVF placement and 186 pa-
tients underwent nonautologous arteriovenous graft place-
ment. CDU evaluation of the pAVFs was conducted to
assess several aspects of fistula maturation including diam-
eter, depth from the skin surface, side branch steal, and the









Table II. Results of color duplex ultrasound examinations
Radiocephal
(n  14)
No abnormality 5 (36%)






Chi-square analysis showed no statistical difference between groups, P .24
abnormalities were found in 29 abnormal examinations.presence of50% stenosis in the arterial inflow, anastomo-
sis, or venous outflow of the arterialized vein. The CDU
surveillance results were compared with preoperative vein
mapping and fistulography when available.
CDU evaluation
CDU examinations were performed by an experienced
sonographer using an ATL HDI 5000/3000 series (Ad-
vanced Technology Laboratories, Bothell, Wash) or Acu-
son Sequoia 512 (Acuson Corporation, Mountain View,
Calif) ultrasound machine with a 4- to 7- or a 5- to
10-MHz linear array transducer. A standard protocol for
pAVF CDU evaluation was followed that included interro-
gation of the arterial inflow, anastomosis, and venous out-
flow tract. pAVF examination included Doppler spectral
analysis and B-mode imaging complemented with color
flow mapping.
Pulsed Doppler spectral analysis. Doppler spectral
analysis was used to measure peak systolic velocity (PSV) at
a 60-degree angle of insonation. An initial sweep of the
arterial inflow, anastomosis, and fistula body with pulsed-
wave Doppler was performed to identify areas of increased
velocity. Representative measurements were taken at the
arterial inflow, anastomosis, and proximal, mid, and distal
venous outflow. The venous outflow was examined to the
level of the axilla, including the central venous system when
possible. Criteria for a hemodynamically significant stenosis
(50%) were based on previously published reports.9,10
Two parameters were used, the PSV and the systolic veloc-
ity ratio (SVR). The SVRwas determined by calculating the
ratio of the highest PSV at the suspect stenosis normalized
to the prestenosis PSV. Hemodynamically significant ste-
nosis of the arterial inflow or venous outflow was indicated
when the SVR was 2. Anastomotic stenoses were deter-
mined by an SVR of 3 and a minimum PSV of 400 cm/s.
Stricter criteria were used at the anastomoses because of
inherently turbulent flow conditions and elevated velocities
caused by the steep pressure gradient.
Side branch steal was defined as high-velocity flow
through a side branch with a significant reduction in veloc-
ity through the main venous outflow. Gray scale median
analysis was first used to identify the branch. PSV was then








8 (35%) 1 (6%) 14 (26%)






4 (17%) 4 (23%) 11 (20%)
pes of abnormalities that were found are listed for each group. A total of 37in d
ic
9. Ty
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branch. A PSV in the branch that was twofold higher than
in the main venous outflow, with a significant velocity
decrease in the main outflow after the branch, was used to
identify side branch steal.
B-mode and color ultrasound examination. B-
mode ultrasound scanning was used to evaluate vein diam-
eter and depth (2 to 5 mm), to help determine presence of
a vein wall thickening and luminal stenosis, and to discrim-
inate between arterial inflow and anastomotic suture line
stenosis. Color flow imaging was used to identify side
branch steal at regions of elevated SVR.
Preoperative vein mapping
The superficial venous system was evaluated for com-
pressibility and diameter using a 4- to 7- or 5- to 10-MHz
linear array probe. The cephalic vein was evaluated from the
level of the wrist to the subclavian vein and the basilic vein
from the forearm to the subclavian vein. Upper extremity
veins 3 mm with tourniquet application and without
evidence of phlebitic mural thickening or intraluminal webs
were considered suitable for pAVF creation. These results
were compared with the results of the postoperative CDU
pAVF surveillance.
Fistulography
Before fistulography, physical examination was used to
select location of the cannulation site and direction of the
introduced sheath in the pAVF venous outflow. Initially,
antegrade fistulography was performed to visualize the
fistula and the draining veins, including the central veins.
Retrograde fistulography with manual downstream occlu-
sion was performed to examine the arterial inflow, distal
vein, and the anastomosis. A hemodynamically significant
stenosis on fistulography was identified as a 50% luminal
diameter reduction on uni- or biplanar views. Other abnor-
malities, including kinking, side branches, and central ste-
nosis, were also identified. The CDU scan and fistulograms
were compared to determine the sensitivity, specificity,
negative predictive value, positive predictive value, and
accuracy of CDU surveillance in detecting hemodynami-
cally significant abnormalities in pAVFs.
Statistical methods
Chi-square analysis was used to compare the difference
in the prevalence of hemodynamically significant abnormal-
ities between fistula types. Difference were considered sta-
tistically significant at P  .05
RESULTS
This retrospective analysis had 14 patients with radio-
cephalic (RC), 23 with brachiocephalic (BC), and 17 with
basilic transposition (BT) pAVFs. Patient demographics are
shown in Table I.
CDU evaluation
Of these 54 patients, 14 (26%) had no abnormality on
their CDU examination; 29 (54%) had a hemodynamicallysignificant abnormality, and 11 (20%) had complete AVF
occlusion. In Table II, patients with abnormal CDU exam-
inations are separated according to pAVF type. The differ-
ence between groups was not significant (P  .25). In the
29 abnormal CDU examinations of patent pAVFs, 37
hemodynamically significant abnormalities were found
(Table II). These included 16 (43%) venous outflow, 12
(33%) anastomotic, and 2 (5%) inflow stenoses. In seven
(19%), branch steal with reduced flow was found. Of the 16
with venous out flow stenosis, two of these patients had
stenosis in their subclavian vein, most likely from previous
Fig 1. Color duplex ultrasound (CDU) and B-mode findings of
venous stenosis in the mid-segment of the venous outflow of a
brachiobasilic transposition primary arteriovenous fistula.A,CDU
velocity profiles: peak systolic velocity (PSV) at stenosis  227
cm/s and PSV prestenosis 85 cm/s. Systolic velocity ratio 2.7,
indicating a luminal stenosis 50%. B, B-mode ultrasound assess-
ment of venous stenosis demonstrating focal valve leaflet
thickening.
steno
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brachiobasilic vein transposition with a hemodynamically
significant abnormality in the mid-segment of the venous
outflow and the corresponding B-mode evaluation. Figure
1B is representative of the culprit stenosis as visualized by
B-mode imaging.
Preoperative vein mapping
Thirty-five of 54 patients (65%) had preoperative vein
mapping. The frequency of preoperative vein mapping
varied among the different surgeons involved in this study.
Although some surgeons obtained preoperative vein map-
ping for 100% of their patients, others only obtained it
when physical examination did not reveal prominent veins.
Thirty (86%) of these studies showed adequate outflow vein
as described in the Methods section. Of five patients with
inadequate veins, two pAVFs were occluded by CDU ex-
amination, two developed hemodynamically significant ab-
normalities, and one pAVF remained patent. Only 2 of the
5 achieved functional patency and both required revision.
Seven of the 11 pAVFs that occluded had preoperative vein
mapping, 5 demonstrated adequate veins, and 2 demon-
Fig 2. Radiocephalic fistulogram demonstrates a 50%
tion demonstrates a hemodynamically significant abnorm
velocity (PSV) at anastomosis  438 cm/s and PSV prestrated inadequate veins.Fistulography
Fistulography was performed in 21 (39%) patent
pAVFs. In each fistulogram, three areas, the arterial inflow
(n  21), anastomosis (n  21), and venous outflow (n 
21), were identified and compared with the CDU findings
(63 segments). Figure 2 demonstrates a fistulogram of a
RC pAVF with an arterial inflow stenosis. The CDU exam-
ination had identified the lesion as an anastomotic stenosis.
Figure 3 demonstrates a fistulogram of a BC pAVF with an
anastomotic stenosis that had been previously identified by
CDU examination. A color flow map is shown in the inset.
In our study, there were 29 patients who had patent
abnormalities found on ultrasound scanning; 18 of these
patients went on to have fistulography. Ten of these fistulae
were revised and remained patent, three were revised and
failed, three remained patent without revision, and in two,
the defect was considered unsalvageable and new access was
created. Three patients with normal ultrasound examina-
tions had normal fistulograms.
CDU validation by fistulography is shown in Table III.
The sensitivity and specificity of CDU examination were
rial stenosis. Color duplex ultrasound (CDU) examina-
at the anastomosis. CDU velocity profiles: peak systolic
sis  130 cm/s. Systolic velocity ratio  3.4.arte
ality93% and 94%, respectively, and accuracy was 97%. The
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tive value was 98%.
DISCUSSION
The high early attrition rate in pAVFs is a well-recog-
nized problem that deserves further investigation. We hy-
pothesized that CDU surveillance may also play an impor-
tant role in defining the etiology of early pAVF failure. To
our knowledge, this is the first report that addresses the
results of CDU surveillance in pAVFs in the intermediate
postoperative period before pAVF cannulation.
In this study, CDU surveillance was employed to assess
54 pAVF within 3 months of creation. The majority of the
patients were referred for postoperative duplex scanning
primarily as a screening evaluation for vein size, depth, and
flow assessment. Patients who were identified as having an
abnormal physical examination (absent thrill, failure to
mature) were excluded. It is our impression, however, that
the physical examination, even when normal, may fail to
detect hemodynamic abnormalities in many instances. We
Fig 3. Brachiobasilic transposition fistulogram demons
sound (CDU) velocity profiles: peak systolic velocity (PS
711 cm/s, and systolic velocity ratio 3.8, indicating an
the anastomotic region.
Table III. Probability values of CDU examination
results compared with fistulography to detect
hemodynamically significant abnormalities
Probability value (%) CDU vs fistulography
Sensitivity 93
Specificity 94
Positive predictive value 82
Negative predictive value 98
Accuracy 97
CDU, Color duplex ultrasound.chose the time interval of 1 to 3 months to ensure healingof the surgical incisions, to give the fistulae adequate time
to mature and adapt to the altered hemodynamic environ-
ment, and to address the role of CDU examination in
detecting abnormalities that may lead to early AVF failure.
Our goal was to identify hemodynamically significant ste-
noses that may contribute to early pAVF failure. To our
surprise, only 26% of the patent pAVFs were devoid of any
significant abnormalities. An alarming 54% had hemody-
namically significant stenoses, and the remaining 20% had
already occluded at the time of examination. In patients
with patent abnormalities, often there was no abnormality
detected on physical examination. There was not a statisti-
cally significant difference between RC, BC, or basilic
transposition pAVFs, although the sample size may have
been too small. Abnormalities were found in patients with
adequate preoperative vein mapping. This suggests that de
novo hemodynamic abnormalities develop after arterializa-
tion of the target vein. This may be attributed to venous
valve malposition and venous intimal hyperplasia due to
inherent turbulent flow conditions or to preexisting vein
wall abnormalities, such as vein wall thickening or occult
central venous stenosis not detected by vein mapping.
Lesions were also identified in fistulae that were created in
the presence of abnormalities identified on preoperative
vein mapping, suggesting that preoperative vein mapping
could be useful in predicting longevity of fistulae. The major-
ity of abnormalities were found in the venous outflow tract,
either stenosis (43%) or side branch steal (19%), suggesting
that they were not caused by poor surgical technique.
Eleven patients were occluded at the time of ultrasound
examination. Two of these patients had inadequate vein
mapping. Four did not have vein mapping, and five patients
with occlusion at the time of ultrasound examination had
a 50% anastomotic stenosis (C). Color duplex ultra-
arterial inflow  185 cm/s (A), PSV at anastomosis 
omotic stenosis (B). Inset shows color flow mapping fortrates
V) at
anastadequate preoperative vein mapping. The reason for these
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be due to surgical technique. Of the 11 occlusions, two
occurred within the first 2 weeks. It is unlikely that earlier
examination/intervention would have improved the out-
come in these cases. Of the remaining nine, three were
examined at 6 weeks and six were examined at 2 to 3
months. It is possible that these occlusions, particularly the
six that were examined at 2 to 3 months, could have been
prevented by earlier intervention. We would recommend a
delay of 4 to 6 weeks to allow for wound healing and initial
fistula maturation, but it is likely that waiting longer than 8
weeks to perform ultrasound surveillance may lead to oc-
clusion secondary to undetected hemodynamic abnormal-
ities.
Preoperative CDU upper extremity vein mapping has
been shown to increase the incidence of pAVF creation and
improve early patency rates by helping to identify suitable
vein conduits for the optimal pAVF creation. Silva et al11
compared a group of patients who received routine preop-
erative vein mapping with historical controls and showed
that pAVF creation improved 14% to 63% of all vascular
access placements. Additionally, improved primary cumu-
lative patency was found in both the pAVF and arterio-
venous graft placed. Other groups have reported increased
rates of pAVF creation using vein mapping but with persis-
tently high or increased rates of primary failure, defined as
early thrombosis or failure to mature.12,13 A report by
Allon et al12 showed that although fistula placement in-
creased from 34% to 64%, initial adequacy rates for dialysis
showed only a slight improvement, from 46% to 54% (P 
.34).
In our study, only 65% of patients had preoperative vein
mapping due to variability in the different surgeons’ prac-
tices. The impact of preoperative vein mapping on type of
access (ie, AVF vs AVG) was not the focus of this study.
Because of the small sample size, it is difficult to assess the
impact of vein mapping on AVF patency. However, func-
tional patency was approximately 60% in patients with
adequate vein mapping and those without vein mapping.
Functional patency is defined as patients who went on to
dialyze through the pAVF. Five patients had AVF placed
after vein mapping showed inadequate (3 mm) vein. In
this group, functional patency was only 40%, with three
occluding and the other two requiring revision. These
results suggest that preoperative vein mapping is helpful
when an adequate outflow is defined. Additionally, the
finding of inadequate outflow may lead to the creation of
access at an alternate site. However, in some instances, the
use of a marginal venous outflow is the only remaining
option for the surgeon to create an autogenous access.
Several studies have compared CDU examination of
arteriovenous fistula and grafts to fistulography (digital
subtraction angiography). Wong et al14demonstrated that
CDU examination was more reliable than clinical assess-
ment in predicting RC fistula failure. Tordoir et al10 com-
pared CDU examination with fistulography in a large series
of 58 diverse patients. The patients varied significantly in
access type (graft vs fistula), age of the access (1 to 160months), and clinical presentation (eg, asymptomatic, low
flow, distal ischemia, aneurysm). Using diagnostic criteria
of PSV alone, they achieved accuracy of 81% to 96% and
sensitivity of 79% to 96%. Chao et al9 compared CDU
examination with digital subtraction angiography in a series
of 38 failing RC fistulae and found a specificity of 96% and
overall accuracy of 97% using combination criteria of PSV
and SVR. These and other studies were invaluable in iden-
tifying CDU surveillance as a valid tool for noninvasive
interrogation of arteriovenous fistulae and grafts. In this
study, we were able to confirm the validity of our findings
with fistulography in 21 patients, with a sensitivity of 93%
and a specificity of 94%. Limitations of CDU examination
in this and other studies include difficulty in interrogating
the anastomotic region. Because of transition of laminar
pulsatile flow to turbulence in the anastomotic region, it is
difficult to distinguish between anastomotic and inflow
arterial stenosis in proximity to the anastomosis.15 B-mode
imaging is helpful in this regard.
Although 29 patients had patent abnormalities on
CDU examination, 11 of these patients did not undergo
fistulography. Four of these patients were lost to follow-up.
Of the other seven, four remained patent, two occluded,
and one was revised at a later date and remained patent after
revision. Fistulography was not performed on these pa-
tients with abnormal CDU evaluation because of surgeon
preference. We would nonetheless recommend fistulogra-
phy after abnormal CDU examination.
Previous studies have shown that aggressive treatment
of nonmaturing and nonfunctioning fistulae is often suc-
cessful.16-18 Such treatments include open revision, percu-
taneous angioplasty or venoplasty, and side branch ligation.
Many lesions can be readily corrected using percutaneous
endoluminal techniques. The findings of this study strongly
suggest that hemodynamically significant abnormalities are
relatively frequent and can be reliably detected using CDU
examination in pAVFs before hemodialysis. In our study, of
the 29 patients who had patent abnormalities, 14 patients
had percutaneous or open intervention and 11 of the 14
(78%) achieved functional patency. It is our contention that
routine CDU surveillance of pAVFs 4 to 6 weeks postop-
eratively will lead to increased early intervention and an
increased functional utilization rate of pAVFs. This topic
deserves further investigation, with a prospective study to
compare patency and utilization rates among patients who
undergo CDU surveillance and those who do not. In such
a study, it would be important that all patients undergo
preoperative vein mapping and that the results of CDU
surveillance be verified with digital subtraction contrast
fistulography.
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Dr Enrico Ascher (Brooklyn, NY). The authors of this paper
recommend duplex scan evaluation of autologous AV access be
performed prior to cannulation or for hemodialysis. Yet, only 65%
of their patients had preoperative duplex studies. Were the patency
and maturation results between the patients who had preoperative
scanning different from the ones who had physical examination
alone?
I’m surprised that 20% of your primary AV fistulas and trans-
positions thrombosed within 3 months. Even more interesting,
was the observation that only 1 out of 17 brachiobasilic transposi-
tions was found not to have a hemodynamically significant stenotic
lesion or occlusion. These findings are divergent from the ones
reported in the literature. It is possible that your criteria to indicate
a hemodynamically significant lesion are too stringent. I believe
that calculation of peak systolic velocity ratios may be misleading,
particularly at or near the anastomosis where size mismatch can be
significant. Additionally, I believe that measurements of the resid-
ual lumen diameter may better reflect the significance of the
flow-limiting lesion than peak systolic velocities and ratios. For
example, a 5-mm residual lumen in a 10-mm vein, which is a 50%
diameter reduction, may be less flow restrictive than a 3-mm
residual lumen in a 5-mm vein, which is 40% diameter reduction.
Dr. Grogan, do you agree with this concept?
It makes intuitive sense that a noninvasive exam such as duplex
scanning of a primary arteriovenous reconstruction be performed
prior to cannulation for hemodialysis. Unfortunately, the data
presented today still need to be corroborated by a larger prospec-
tive study where volume flows rather than peak systolic velocities
alone are measured, since these appear to be better indicators of
fistula maturation. Did you measure volume flows? And if yes, did
they correlate with the findings found in the fistulograms?
Dr Grogan. Unfortunately, because of the retrospective na-
ture of this study, we do not have preoperative vein mapping on all
of our patients. It has been shown by groups such as your own that
preoperative vein mapping can significantly improve not only the
rate of AV fistula creation, but also AV fistula patency rates, byWe do not think that physical exam is adequate for selecting
the location or the type of vascular access. However, it would
require a randomized prospective trial in which all patients had
undergone preoperative vein mapping to really differentiate the
effect of preoperative versus postoperative ultrasound evaluation.
In regards to your second question, it is true that we found
numerous abnormalities in our brachiobasilic transpositions,
which, in the published literature, have the highest primary pa-
tency rates. This may be due to increased turbulent flow in these
fistulas as they generally have the biggest vein diameter. The
natural history of these lesions that we identified is not known. And
it’s possible that, although we didn’t use different criteria when
looking at arm or forearm fistulas, different criteria may be re-
quired.We did look at patients using gray-scale criteria and an SVR
of 3:1 and found that the sensitivity of our exam decreased from
the 90% to the 70%. So because we were trying to screen patients
and find as many abnormalities as possible, we chose the criteria
that I mentioned in my presentation.
Finally, flow rates were performed in many of our patients,
however, not all of them. Generally, we found flow rates between
300 and 700 even when hemodynamic abnormalities were found.
Dr F. LoGerfo (Boston, Mass). I was interested in your
concept of vein valve malposition due to the high flow rate, which
could occur, because the valve itself, even though it’s in essentially
in a reversed position, as the vein is completely distended, can
become a partial obstruction, and that these very high flow rates
then create a very significant flow disturbance. How many of your
lesions would you ascribe to this category? Does it occur in
specifically one type of fistula or another? And do you think that
incising those valves beforehand might reduce this phenomenon?
Dr Grogan. I can’t speak to the different causes for the
hemodynamic abnormalities we found. It’s our feeling that prob-
ably this finding would be more common in brachiobasilic trans-
positions because of the higher flow rates that we found there. But
it’s a topic that would require further investigation.
